vs
Side-by-side financial comparison of WARRIOR MET COAL, INC. (HCC) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
WARRIOR MET COAL, INC. is the larger business by last-quarter revenue ($458.6M vs $207.8M, roughly 2.2× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 15.8%, a 41.6% gap on every dollar of revenue.
Warrior Met Coal, Inc. (ticker HCC) is a U.S.-headquartered mining enterprise that produces and distributes high-grade metallurgical coal, a key raw material for steel production. It serves steel manufacturers and industrial clients across core markets including North America, Europe, and Asia.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
HCC vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $458.6M | $207.8M |
| Net Profit | $72.3M | $119.2M |
| Gross Margin | 36.7% | — |
| Operating Margin | 17.3% | 52.2% |
| Net Margin | 15.8% | 57.4% |
| Revenue YoY | 52.1% | — |
| Net Profit YoY | — | 330.1% |
| EPS (diluted) | $1.37 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $458.6M | — | ||
| Q4 25 | $384.0M | — | ||
| Q3 25 | $328.6M | $207.8M | ||
| Q2 25 | $297.5M | — | ||
| Q1 25 | $299.9M | — | ||
| Q4 24 | $297.5M | — | ||
| Q3 24 | $327.7M | $0 | ||
| Q2 24 | $396.5M | $0 |
| Q1 26 | $72.3M | — | ||
| Q4 25 | $23.0M | — | ||
| Q3 25 | $36.6M | $119.2M | ||
| Q2 25 | $5.6M | — | ||
| Q1 25 | $-8.2M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $41.8M | $-51.8M | ||
| Q2 24 | $70.7M | $-52.8M |
| Q1 26 | 36.7% | — | ||
| Q4 25 | 29.5% | — | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 23.9% | — | ||
| Q1 25 | 18.1% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 29.3% | — | ||
| Q2 24 | 34.1% | — |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 9.0% | — | ||
| Q3 25 | 6.3% | 52.2% | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | -1.4% | — | ||
| Q3 24 | 11.9% | — | ||
| Q2 24 | 17.9% | — |
| Q1 26 | 15.8% | — | ||
| Q4 25 | 6.0% | — | ||
| Q3 25 | 11.1% | 57.4% | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | -2.7% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 17.8% | — |
| Q1 26 | $1.37 | — | ||
| Q4 25 | $0.43 | — | ||
| Q3 25 | $0.70 | $1.33 | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $-0.16 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.80 | $-0.60 | ||
| Q2 24 | $1.35 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $233.2M | $786.9M |
| Total DebtLower is stronger | $154.4M | — |
| Stockholders' EquityBook value | — | $1.1B |
| Total Assets | $2.8B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $233.2M | — | ||
| Q4 25 | $300.0M | — | ||
| Q3 25 | $336.3M | $786.9M | ||
| Q2 25 | $383.3M | — | ||
| Q1 25 | $454.9M | — | ||
| Q4 24 | $491.5M | — | ||
| Q3 24 | $583.2M | $920.0M | ||
| Q2 24 | $709.0M | $701.7M |
| Q1 26 | $154.4M | — | ||
| Q4 25 | $154.3M | — | ||
| Q3 25 | $154.1M | — | ||
| Q2 25 | $153.9M | — | ||
| Q1 25 | $153.8M | — | ||
| Q4 24 | $153.6M | — | ||
| Q3 24 | $153.5M | — | ||
| Q2 24 | $153.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | $1.1B | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | $1.2B | ||
| Q2 24 | $2.0B | $931.7M |
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.7B | $1.2B | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | $1.2B | ||
| Q2 24 | $2.6B | $973.7M |
| Q1 26 | — | — | ||
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.07× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $76.1M | — | ||
| Q3 25 | $104.7M | $142.2M | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $54.2M | — | ||
| Q3 24 | $62.2M | $-49.2M | ||
| Q2 24 | $147.0M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.31× | — | ||
| Q3 25 | 2.86× | 1.19× | ||
| Q2 25 | 6.70× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.68× | — | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 2.08× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCC
| Sales | $448.5M | 98% |
| Other revenues | $10.1M | 2% |
IDYA
Segment breakdown not available.
